Sector Gamma As buys $20,503,567 stake in Masimo Corporation (MASI)

Masimo Corporation (MASI) : Sector Gamma As scooped up 33,590 additional shares in Masimo Corporation during the most recent quarter end , the firm said in a disclosure report filed with the SEC on Aug 11, 2016. The investment management firm now holds a total of 352,053 shares of Masimo Corporation which is valued at $20,503,567.Masimo Corporation makes up approximately 3.92% of Sector Gamma As’s portfolio.

Other Hedge Funds, Including , Martingale Asset Management L P reduced its stake in MASI by selling 3,000 shares or 12.07% in the most recent quarter. The Hedge Fund company now holds 21,853 shares of MASI which is valued at $1,272,719. Masimo Corporation makes up approx 0.02% of Martingale Asset Management L P’s portfolio.Segall Bryant Hamill reduced its stake in MASI by selling 58,744 shares or 36.08% in the most recent quarter. The Hedge Fund company now holds 104,067 shares of MASI which is valued at $6,060,862. Masimo Corporation makes up approx 0.15% of Segall Bryant Hamill’s portfolio. Stanley-laman Group Ltd. added MASI to its portfolio by purchasing 5,270 company shares during the most recent quarter which is valued at $295,015. Masimo Corporation makes up approx 0.11% of Stanley-laman Group Ltd.’s portfolio.First National Bank Of Omaha boosted its stake in MASI in the latest quarter, The investment management firm added 25 additional shares and now holds a total of 13,525 shares of Masimo Corporation which is valued at $716,555. Masimo Corporation makes up approx 0.05% of First National Bank Of Omaha’s portfolio.

Masimo Corporation opened for trading at $58.23 and hit $58.89 on the upside on Tuesday, eventually ending the session at $58.64, with a gain of 0.57% or 0.33 points. The heightened volatility saw the trading volume jump to 3,08,688 shares. Company has a market cap of $2,894 M.

On the company’s financial health, Masimo Corporation reported $0.57 EPS for the quarter, beating the analyst consensus estimate by $ 0.16 according to the earnings call on Aug 3, 2016. Analyst had a consensus of $0.41. The company had revenue of $172.64 million for the quarter, compared to analysts expectations of $166.03 million. The company’s revenue was up 10.9% compared to the same quarter last year. During the same quarter in the previous year, the company posted $0.36 EPS.

Many Wall Street Analysts have commented on Masimo Corporation. Company shares were Reiterated by Wedbush on Aug 4, 2016 to “Outperform”, Firm has raised the Price Target to $ 63 from a previous price target of $60 .

Masimo Corporation is a global medical technology company that develops manufactures and markets non-invasive patient monitoring products. The Company’s core business is measure-through-motion and low-perfusion pulse oximetry monitoring known as Masimo Signal Extraction Technology (SET) pulse oximetry. Its product offerings include non-invasive optical blood constituent monitoring optical organ oximetry monitoring electrical brain function monitoring acoustic respiration monitoring and optical gas monitoring. In addition the Company offers Root patient monitoring and connectivity platform the Radical-7 bedside and portable patient monitor and the Radius-7 wearable wireless patient monitor. The Company also has the Patient SafetyNet remote patient surveillance monitoring system which allows up to 80 patients to be monitored simultaneously through a central station or remotely by care providers through their pagers or smart phones.

Comments (0)

Leave a Reply

Your email address will not be published. Required fields are marked *

Masimo Corporation - Is it time to Sell?

Top Brokerage Firms are advising their investors on Masimo Corporation. Subscribe to MoneyFlowIndex.Org Pre-Market Alerts, You will be the first to know the street buzz.